Scientists identified an autoimmune mechanism linked to a major IBD risk gene, opening the door to targeted diagnosis and personalized therapies for thousands of patients.
Researchers have identified a distinct subgroup of inflammatory bowel disease (IBD) patients whose condition appears to be driven by an autoimmune response that disables a key immune-regulating molec… [+7101 chars]
Discussion (0)
No comments yet. Be the first to share your thoughts!
Join the Conversation
You need to be logged in to leave a comment.
Sign In Create Account